Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
GENE:
VTCN1 (V-Set Domain Containing T Cell Activation Inhibitor 1)
i
Other names:
VTCN1, V-Set Domain Containing T Cell Activation Inhibitor 1, B7-H4, B7H4, B7S1, V-Set Domain-Containing T-Cell Activation Inhibitor 1, Immune Costimulatory Protein B7-H4, B7 Superfamily Member 1, B7 Family Member, H4, B7 Homolog 4, FLJ22418, B7h.5, B7x, T Cell Costimulatory Molecule B7x, T-Cell Costimulatory Molecule B7x, Protein B7S1, PRO1291, VCTN1, B7X
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
79679
Associations
(13)
News
Trials
VERI cancer hierarchy
Reset Filters
VTCN1 overexpression
Bladder Cancer
VTCN1 overexpression
Bladder Cancer
cisplatin
Sensitive: C3 – Early Trials
cisplatin
Sensitive
:
C3
cisplatin
Sensitive: C3 – Early Trials
cisplatin
Sensitive
:
C3
VTCN1 overexpression
Bladder Cancer
VTCN1 overexpression
Bladder Cancer
PD-L1 inhibitor
Sensitive: C3 – Early Trials
PD-L1 inhibitor
Sensitive
:
C3
PD-L1 inhibitor
Sensitive: C3 – Early Trials
PD-L1 inhibitor
Sensitive
:
C3
VTCN1 underexpression
Breast Cancer
VTCN1 underexpression
Breast Cancer
PF-08046048
Sensitive: D – Preclinical
PF-08046048
Sensitive
:
D
PF-08046048
Sensitive: D – Preclinical
PF-08046048
Sensitive
:
D
VTCN1 underexpression
Ovarian Cancer
VTCN1 underexpression
Ovarian Cancer
PF-08046048
Sensitive: D – Preclinical
PF-08046048
Sensitive
:
D
PF-08046048
Sensitive: D – Preclinical
PF-08046048
Sensitive
:
D
VTCN1 overexpression
Solid Tumor
VTCN1 overexpression
Solid Tumor
GEN1047
Sensitive: D – Preclinical
GEN1047
Sensitive
:
D
GEN1047
Sensitive: D – Preclinical
GEN1047
Sensitive
:
D
VTCN1 overexpression
Solid Tumor
VTCN1 overexpression
Solid Tumor
PF-08046048
Sensitive: D – Preclinical
PF-08046048
Sensitive
:
D
PF-08046048
Sensitive: D – Preclinical
PF-08046048
Sensitive
:
D
VTCN1 underexpression
Solid Tumor
VTCN1 underexpression
Solid Tumor
AZD8205 + AZD5305
Sensitive: D – Preclinical
AZD8205 + AZD5305
Sensitive
:
D
AZD8205 + AZD5305
Sensitive: D – Preclinical
AZD8205 + AZD5305
Sensitive
:
D
VTCN1 underexpression
Cholangiocarcinoma
VTCN1 underexpression
Cholangiocarcinoma
AZD8205
Sensitive: D – Preclinical
AZD8205
Sensitive
:
D
AZD8205
Sensitive: D – Preclinical
AZD8205
Sensitive
:
D
VTCN1 underexpression
Ovarian Cancer
VTCN1 underexpression
Ovarian Cancer
AZD8205
Sensitive: D – Preclinical
AZD8205
Sensitive
:
D
AZD8205
Sensitive: D – Preclinical
AZD8205
Sensitive
:
D
VTCN1 underexpression
Triple Negative Breast Cancer
VTCN1 underexpression
Triple Negative Breast Cancer
AZD8205
Sensitive: D – Preclinical
AZD8205
Sensitive
:
D
AZD8205
Sensitive: D – Preclinical
AZD8205
Sensitive
:
D
VTCN1 expression
Solid Tumor
VTCN1 expression
Solid Tumor
PF-08046048
Sensitive: D – Preclinical
PF-08046048
Sensitive
:
D
PF-08046048
Sensitive: D – Preclinical
PF-08046048
Sensitive
:
D
VTCN1 expression + DDR
Solid Tumor
VTCN1 expression + DDR
Solid Tumor
AZD8205
Sensitive: D – Preclinical
AZD8205
Sensitive
:
D
AZD8205
Sensitive: D – Preclinical
AZD8205
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.